MindWalk Holdings (HYFT) Non-Current Assets (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Non-Current Assets of $3.8 million for Q2 2026, down 79.16% year-over-year from $18.1 million in Q2 2025, and up 25.12% quarter-over-quarter from $3.0 million in Q1 2026.
MindWalk Holdings (HYFT) Non-Current Assets (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Non-Current Assets for 7 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 79.16% year-over-year to $3.8 million; the TTM figure through Apr 2026 stood at $13.2 million (down 87.51% YoY), while the FY2026 annual figure was $3.8 million, down 79.6% from the prior year.
- Non-Current Assets advanced to $3.8 million in Q2 2026 per HYFT's latest filing, from $3.0 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $47.1 million in Q1 2023 and bottomed at $3.0 million in Q1 2026.
- Historically, Non-Current Assets has averaged $29.3 million across 5 years, with a median of $35.5 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets jumped 275.42% — and 2025, when it plunged 90.95%.
- MindWalk Holdings' Non-Current Assets stood at $45.2 million in 2022, then retreated by 1.83% to $44.4 million in 2023, then dropped by 21.72% to $34.8 million in 2024, then slumped by 90.95% to $3.1 million in 2025, then rose by 19.56% to $3.8 million in 2026.
- Business Quant data shows HYFT's Non-Current Assets at $3.8 million in Q2 2026, $3.0 million in Q1 2026, and $3.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 564.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.76 Mn |
| Jan 31, 2026 | 3.01 Mn |
| Oct 31, 2025 | 3.15 Mn |
| Jul 31, 2025 | 3.27 Mn |
| Apr 30, 2025 | 18.05 Mn |
| Jan 31, 2025 | 17.46 Mn |
| Oct 31, 2024 | 34.76 Mn |
| Jul 31, 2024 | 35.26 Mn |
| Apr 30, 2024 | 35.77 Mn |
| Jan 31, 2024 | 47.07 Mn |
| Oct 31, 2023 | 44.40 Mn |
| Jul 31, 2023 | 45.60 Mn |
| Apr 30, 2023 | 45.10 Mn |
| Jan 31, 2023 | 47.13 Mn |
| Oct 31, 2022 | 45.23 Mn |
| Jul 31, 2022 | 41.10 Mn |
| Apr 30, 2022 | 44.35 Mn |
| Jan 31, 2022 | 12.55 Mn |
| Oct 31, 2021 | 13.03 Mn |
| Jul 31, 2021 | 14.34 Mn |